Resource centre

Main menu

63 results

Biopharma

Publication
Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy
January 16 2026
Webinar
Advancing rAAV Characterisation with Oxford Nanopore Sequencing
November 20 2025
Brochure
Brochure: biopharma — cell and gene therapies
November 14 2025
Getting started guide
Getting started guide: biopharma
October 15 2025
Workflow
Workflow overview: amplicon sequencing
September 15 2025
Publication
Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario
September 6 2025
Workflow
Workflow overview: pharmacogenomics with adaptive sampling
August 5 2025
Case study
Case study: streamlining routine CRISPR validation with Oxford Nanopore sequencing
July 30 2025
Workflow
Workflow overview: AAV sequencing
June 23 2025
Video
Webinar: Rapid, comprehensive AAV genomic profiling made simple
June 11 2025
Publication
Long read sequencing reveals transgene concatemerisation and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes
June 4 2025
Poster
EPI2ME end-to-end workflows for biopharma quality control of plasmids and mRNA
May 20 2025
Video
Stepping into the future of nanopore protein sequencing
May 19 2025
Video
Nanopore sequencing reveals psilocybin-induced brain 5mC/5hmC epigenetic changes
May 19 2025
Video
Masterclass: How to sequence full-length plasmids in your own lab | LC25
May 19 2025
Brochure
Flyer: pharmacogenomics with Twist
May 6 2025
Publication
A sensitive sample preparation pipeline for adventitious virus detection using Oxford Nanopore sequencing
April 24 2025
Publication
Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing
April 19 2025
Brochure
Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore
April 16 2025
Publication
Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines
April 16 2025

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

About Oxford Nanopore

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Focus areas

Resource Centre

Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy

Advancing rAAV Characterisation with Oxford Nanopore Sequencing

Brochure: biopharma — cell and gene therapies

Getting started guide: biopharma

Workflow overview: amplicon sequencing

Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario

Workflow overview: pharmacogenomics with adaptive sampling

Case study: streamlining routine CRISPR validation with Oxford Nanopore sequencing

Workflow overview: AAV sequencing

Webinar: Rapid, comprehensive AAV genomic profiling made simple

Long read sequencing reveals transgene concatemerisation and vector sequences integration following AAV-driven electroporation of CRISPR RNP complexes

EPI2ME end-to-end workflows for biopharma quality control of plasmids and mRNA

Stepping into the future of nanopore protein sequencing

Nanopore sequencing reveals psilocybin-induced brain 5mC/5hmC epigenetic changes

Masterclass: How to sequence full-length plasmids in your own lab | LC25

Flyer: pharmacogenomics with Twist

A sensitive sample preparation pipeline for adventitious virus detection using Oxford Nanopore sequencing

Evaluation of the loading capacity and patterns of packaged DNA in AAV genomes of different sizes using long-read sequencing

Introductory guide: unlocking the biopharma development pipeline with Oxford Nanopore

Re-adenylation by TENT5A enhances efficacy of SARS-CoV-2 mRNA vaccines

shared.filter

Products

Research areas

Techniques